Dyadic International, Inc. (DYAI)
NASDAQ·Healthcare·Biotechnology
$1.11
+4.72%
Mkt Cap $28.95M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+170.3%
Consensus $3.00 vs current $1.11
NASDAQ·Healthcare·Biotechnology
$1.11
+4.72%
Mkt Cap $28.95M
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
+170.3%
Consensus $3.00 vs current $1.11